Mar. 4, 2025

Business & Products

Sumitomo Chemical Launches Three-Year Corporate Business Plan for Fiscal
2025 to 2027 with the Slogan Leap Beyond: Returning to a Growth Trajectory

Mar. 3, 2025

IR

Notice Regarding Sumitomo Chemical's Transition to a Company with an Audit and Supervisory Committee

Feb. 6, 2025

IR

Sumitomo Chemical Agrees to Accept a Tender Offer by Dai Nippon Toryo for Shares of an Associate Accounted for Using the Equity Method

Feb. 4, 2025

IR

Notice Regarding the Recording of Extraordinary Income in Non-Consolidated Financial Statements Due to the Transfer of a Portion of Shares Held by Sumitomo Chemical in Sumitomo Bakelite

Feb. 3, 2025

IR

Sumitomo Chemical Appoints New Chairman and President

Feb. 3, 2025

IR

Summary of Consolidated Financial Results for Third Quarter Fiscal Year 2024

Feb. 3, 2025

IR

Notice Regarding the Recording of Other Operating Income in Consolidated Financial Statements and Extraordinary Income in Non-Consolidated Financial Statements Due to the Transfer of a Portion of Shares Sumitomo Chemical Holds in a Consolidated Subsidiary

Feb. 3, 2025

IR

Notice Concerning Share of Loss of Investments Accounted for Using the Equity Method and Finance Income (Foreign Exchange Gain), and Non-operating Income (Foreign Exchange Gain) in Non-consolidated Financial Statements

Dec. 26, 2024

IR

"Conference on Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture" have been released.

Dec. 24, 2024

IR

Notice Regarding Changes in Consolidated Subsidiaries: Sumitomo Chemical to Implement Fundamental Structural Reform of its Large-Size Liquid Crystal Display (LCD) Polarizing Film Business

Dec. 5, 2024

IR

"Investors' Meeting for the Business Strategy (Agro & Life Solutions, ICT & Mobility Solutions)" have been released.

Dec. 2, 2024

IR

Notice Regarding the Recording of Other Operating Income in Consolidated Financial Statements and Extraordinary Income in Non-Consolidated Financial Statements due to the Transfer of Shares of a Consolidated Subsidiary

Oct. 31, 2024

IR

Annual Report 2024 and Sustainability Report 2024 have been published

Oct. 31, 2024

IR

"Investors' Meeting for FY2024 1st Half Financial Results, Management Priorities and Business Strategies" have been released.

Oct. 30, 2024

IR

Notice Concerning Finance Expenses (Foreign Exchange Loss) and Non-operating Expenses (Foreign Exchange Loss) in Non-consolidated Financial Statements

Oct. 30, 2024

IR

Sumitomo Chemical Reports Unrealized Losses on Securities as of September 30, 2024

Oct. 30, 2024

IR

Sumitomo Chemical Announces Revisions to Its Financial Forecast for the Full Year Ending March 31, 2025

Oct. 30, 2024

IR

Summary of Consolidated Financial Results for Second Quarter (Interim Period) Fiscal Year 2024

Sep. 18, 2024

IR

Notice Regarding the Recording of Other Operating Income in Consolidated Financial Statements and Extraordinary Income in Non-Consolidated Financial Statements due to the Transfer of a Portion of Shares Sumitomo Chemical Holds in an Associate

Sep. 6, 2024

IR

Notice Regarding Determination of Issuance Condition for the Third Publicly Offered Hybrid Bonds (Subordinated Bonds)